Dr. Wolfe is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
Univ at Buffalo, SUNY
Buffalo General Medical Center, 100 High St.
Buffalo, NY 14203Phone+1 716-859-2024Fax+1 716-859-2430- Is this information wrong?
Education & Training
- University of Pennsylvania Health SystemResidency, Neurology, 1990 - 1993
- University of Pennsylvania Health SystemInternship, Internal Medicine, 1989 - 1990
- University of Texas Southwestern Medical SchoolClass of 1989
Certifications & Licensure
- CT State Medical License 2022 - 2025
- TX State Medical License 1990 - 2025
- NY State Medical License 2012 - 2025
- PA State Medical License 1991 - 1994
- American Board of Psychiatry and Neurology Neurology
- American Board of Psychiatry and Neurology Clinical Neurophysiology
- American Board of Psychiatry and Neurology Neuromuscular Medicine
Awards, Honors, & Recognition
- Buffalo Spree Magazine Castle Connolly, 2013-2014
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011-2012
- Super Doctor SuperDoctors.com
- Join now to see all
Clinical Trials
- Thymectomy Trial in Non-Thymomatous Myasthenia Gravis Patients Receiving Prednisone Therapy Start of enrollment: 2006 Jun 01
- Efficacy of Prednisone In the Treatment of Ocular Myasthenia Start of enrollment: 2011 Dec 01
- International Guillain-Barré Syndrome Outcome Study Start of enrollment: 2012 May 01
Publications & Presentations
PubMed
- 1 citationsPhase 2 trial in acetylcholine receptor antibody-positive myasthenia gravis of transition from intravenous to subcutaneous immunoglobulin: The MGSCIg study.Mamatha Pasnoor, Vera Bril, Todd Levine, Jaya Trivedi, Nicholas J Silvestri, Milind Phadnis, Hans D Katzberg, David S Saperstein, Gil I Wolfe, Laura Herbelin, Kiley Hi...> ;European Journal of Neurology. 2023 May 1
- 35 citationsPhase 2 Trial of Rituximab in Acetylcholine Receptor Antibody-Positive Generalized Myasthenia Gravis: The BeatMG Study., , , , , , , , , , , , , , , , , , , , , , , , , , , , > ;Neurology. 2021 Dec 2
- 16 citationsIgG regulation through FcRn blocking: A novel mechanism for the treatment of myasthenia gravisGil I. Wolfe, E. Sally Ward, Hans de Haard, Peter Ulrichts, Tahseen Mozaffar, Mamatha Pasnoor, Gestur Vidarsson> ;Journal of the Neurological Sciences. 2021 Nov 15
- Join now to see all
Press Mentions
- COVID-19 May Complicate Neuromuscular Conditions Such as MG, Review FindsAugust 7th, 2020
- Pharmacy Times Continuing Education™ to Present Specialty Pharmacy CE Symposia in Washington, D.CAugust 28th, 2019
- “Chemical Plasmapheresis” Drug for Myasthenia Gravis Is Safe, Lowers Antibodies, and Produces Hints of Efficacy in Phase 2 TrialJuly 11th, 2019
- Join now to see all
Other Languages
- Hebrew
Hospital Affiliations
- KALEIDA HealthBuffalo, New York
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: